Checkpoint Inhibition Before Haploidentical Stem Cell Transplantation in Relapsed or Refractory Hodgkin Lymphoma (Hl) Patients is Associated with Higher PFS without Increased Toxicities

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2019)

引用 0|浏览48
暂无评分
摘要
Immune checkpoint inhibition (CPI) before allogeneic stem cell transplantation (SCT) could enhance allogeneic T-cell responses, increasing both the graft-versus-tumor effect and the incidence of immune complications.
更多
查看译文
关键词
checkpoint inhibitors,haploidentical transplantation,Hodgkin lymphoma,post transplant cyclophosphamide,HL
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要